Capital Fund Management (CFM)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-29,243
Closed -$1.29M 940
2024
Q2
$1.29M Buy
+29,243
New +$1.29M ﹤0.01% 544